This round is no longer accepting investments, but hundreds just like it are live now.

Log In


On-demand virtual care reinvented

XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

$255,146.53 Raised

Reasons to Invest

  • The metaverse global market opportunity is projected to reach 800 billion by 2024 and the fast-growth telehealth market is predicted to reach a value of $70.19 billion by 2026XRHealth has already contributed significantly to this projection. In 2021, XRHealth generated over $1M of this revenue in YTD and our QoQ growth has been 300+%.
  • XRHealth was operating clinics in the metaverse before there was a common word to describe the next evolution of the internet or web 3.0. To date, XRHealth has treated over 2,000 patients in 5 virtual clinics. XRHealth plans to be a central player in DTx technology (aka Digital Therapeutics) using virtual and augmented reality to offer therapy in the metaverse.
  • XRHealth is poised to be an industry leader in VR/AR therapy due to strict adherence to FDA and HIPPA regulations during the past 5 years. XRHealth currently has 3 approved patents, 8 FDA registered medical applications, and 6 3rd party apps already in use. The digital services are covered by insurance thanks to changes in CPT codes during the pandemic, making it one of the most trustworthy digital health services.


Bringing Patient Care Into the Metaverse

XRHealth is spearheading the VR/AR therapy revolution by combining proprietary FDA-registered medical virtual reality (VR/AR) therapy with conventional telehealth solutions to offer patients personalized care they need for chronic conditions in the metaverse.

1:1 Virtual Therapy With Virtual Reality

From the Comfort of Home

A comprehensive therapeutic at-home care solution for multiple chronic conditions:

Our Virtual Therapy is Safe, Secure and Loved by Our Patients:

We also offer Software as a Service (Saas) to providers, hospitals, and rehabilitation centers.

Our Story

XRHealth was founded by Eran Orr, an Air Force veteran pilot and an industry early adopter of virtual reality (VR). After suffering from chronic neck pain caused by heavy helmets used during flights, he saw a need to bring his VR expertise into healthcare. Based on his experience, he believed VR was the perfect tool for simulated training to maximize the effectiveness of physical therapy.

So...he set on a new mission to help others recover from pain by using VR. He teamed up with interdisciplinary experts including medical professionals, data scientists, graphic artists, and more to make it happen. XRHealth became the first company to combine a telehealth online clinic with gamified virtual reality facilitated by licensed therapists.

The Problem

Current Telehealth Technology Provides Limited Treatment

1. Chronic conditions affect 60% of Americans, with more than 40% experiencing 2 or more conditions. Some conditions may require long waits to receive care to heavy patient loads in clinics.

2. Despite the need for ongoing care, patients are often over-taxed due to 'commuter fatigue,' pain of care, or boredom. As a result, patients have a 50% average treatment adherence rate and 70% churn rate (in comparison with 91.2% adherence and 10% churn with XRHealth).

3. Digital at-home services became the 'new normal,' which highlighted the gaps in brick and mortar care including the lack of data, real-time progress insights, easy-to-use platforms and interfaces, access to clinicians outside of therapy, and more.

Source 1Source 2, Source 3

THE Market

A Fast Growing Industry With Impact Across Healthcare Verticals 

The fast-growth telehealth market is projected to grow to $70.19 billion by 2026 and the metaverse global market is expected to climb to 800 billion by 2024. Telehealth services doubled during the pandemic and is expected to be the 'new normal' as lifestyles adjust and digital services improve.

The pandemic doubled the number of people who have used telehealth from 39.4% pre-COVID-19 to 79.5% post-quarantine. 

Our services meet the specific needs of the following patient markets:

Our services meet the specific needs of the following patient markets: 

The Solution

Building Therapy in the Metaverse

  • Our platform combines immersive VR/AR technology with telehealth services, licensed clinicians, and advanced data analytics for an all-in-one innovative solution for patients to receive high-quality care in the comfort of their homes via the Metaverse (the new term used to describe the virtual world).
  • We provide our patients with enjoyable treatments that feel like less work and more fun. Patients participate in weekly sessions with a licensed therapist who guides and monitors their treatment in real-time and adjusts therapy protocols remotely in the VR/AR headset.
  • In between sessions, the patient practices virtual reality exercises according to the tailored VR digital treatment plan (in addition to conventional exercises that may be suggested).
  • Patients use our mobile app to track their own progress, chat with their therapist, and communicate easily with clinic staff.
  • After each therapy session, the patient's insurance company is billed for telehealth services and Remote Therapeutic Monitoring (RTM) (a newly introduced CPT code now used to support the growth of digital therapeutics and foster the development of remote patient services).

Virtual Worlds, Real Results

Patients enjoy therapeutic exercises that feel more like games than work to promote adherence to treatment. Patients and therapists gain instant progress insights from biofeedback and other data-tracking mechanisms that flows from the headset to the XRHealth platform. Therapists can use this data to personalize treatments for optimal success.

XRHealth takes digital health services to the web 3.0 revolution in the metaverse 

In the old world, you needed to drive to a clinic or hospital and go to a specific room to meet with a therapist who is often chosen by the clinical setting or HMO plan. But the way we are conducting therapy is rapidly changing to match the modern lifestyle.

In the metaverse, you can enter any virtual treatment room and meet any therapist you want (or meet other patients) no matter where they are. And we believe this fosters better compliance with treatment, which we are already seeing from primary surveys.

That's why we are building some of the first virtual clinics in the metaverse. 

This is the new world:

  1. Quantified data
  2. Real-time progress analysis
  3. Accessibility to care
  4. Improved patient experience

Gamified therapy fosters better treatment compliance because its fun! 

Better Results = Better Quality of Life 

XRHealth patients across multiple health verticals report a decrease in symptoms related to chronic pain, stress & anxiety, and neurological conditions.

Pain Management vertical:

Behavioral Health vertical:

Neurological Disorders vertical:

Business Model

Our GO TO MARKET Strategy Combines:

B2C: Direct to Consumer

Our Insurance Coverage

B2B: SaaS - Virtual Treatment Rooms

In our B2B model, inpatient and outpatient facilities partner with XRHealth to expand their skilled therapy and rehabilitation services. We generate revenue throughout the process. 

Our Partner Providers

The Patient's Voice

"It's better to have 100 users love you than 1 million [sic] kinda like you. The true seed of scale is love, and you can't buy it, hack it, or game it", said Sam Altman, Master of scale.

Our Growth

Growth on all fronts 

The XRhealth platform expansion drives growth! To date, XRHealth has treated over 2,000 patients in 5 operating virtual clinics. 

Therapy in the metaverse is no longer a dream or science fiction. It's already working, making it clear that the new reality of healthcare is in immersive, digital applications.

Let's take a look at the numbers. XR Health is expanding exponentially to meet the growing demand, with a current growth rate of 400%.

*The above graphic includes unaudited financial information and is subject to change. From Q1-Q3 2021, the Company has achieved $1.1M in revenue. The Company is pending their final Q4 unaudited data. Please refer to the risk factors in our Form C regarding forward looking information and our financial information.

Future Growth Plan

The use of funds is focused on

(1) Clinic expansion

(2) RnD - platform expansion

Insert Image
Drop image
(or click)

Loading image


1330 Beacon St STE 209
Brookline, MA 02446

XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.


Hillel Bachrach

Hillel Bachrach

Board of Directors

Entrepreneur with more than 40 years of experience managing and funding the commercial global introduction of innovative and revolutionary medical and life science technologies. After a successful career as an entrepreneur starting many companies that were either sold or went public, in 2005 Hillel founded 20/20 HealthCare Partners, an investment company where he is the Managing Partner.

Eran Orr

Eran Orr

CEO, Founder & Director

During a 15-year career as an F-16 fighter pilot in the Israeli Air Force and several executive positions, Eran has established himself as a worldwide leader in the XR and health industries and is an official Forbes Councils Member.

Gilad Meiri

Gilad Meiri

Board of Directors

Gilad is a serial entrepreneur and active angel investor. He currently acts as a board member and the CFO of Cupixel. Before that Gilad founded and was the CEO of Neura (acquired by Otonomo Technologies) and Spicebox Labs. Gilad is also a director in publicly traded Third Eye Systems (TASE: THES).

Miki Levy

Miki Levy

CTO & Co-Founder

During a 16-year career as an executive officer in the Israeli Air Force Miki received the IDF Major General's Award of Excellence. Miki serves as the president of the VR/AR Association, Tel Aviv chapter.

Deepa Javeri

Deepa Javeri

Chief Financial Officer

During a 15-year career in financial services ranging from equity portfolio management at Merrill Lynch to M&A banking at Morgan Stanley, Deepa developed broad expertise in capital markets, financial planning, and corporate strategy.

Gal Hayut

Gal Hayut

Board of Directors

After more than 13 years at the Venture Capital Industry and 4 years as the Managing Director of The Portland Trust Israel, a nonprofit 'action-tank" that leads economic development projects in the undeserved population in Israel, Gal recently established Bridges Israel, together with his two partners. Bridges Israel an impact investments fund that invest in businesses that operate among the underserved population in Israel as well as in "tech-for good" Start-ups

Sergey Gribov

Sergey Gribov

Board of Directors

Technology entrepreneur and investor with more than 20 years of experience. Sergey has a lot of experience across such sectors as software development, VoIP, cybersecurity, digital health, finance, and others. Today Sergey is an investor, board member, or mentor in several startups across US and Israel. Sergey holds an MBA, Sloan Fellow from MIT and B.Sc. in Computer Science, Cum Laude from Beer-Sheva University.


Feb 9, 2022
$10k - $1.07M
Common Stock
Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Early Bird

Early Bird Bonus - First 7 days | XRHealth t-shirt


Tier 1 perk ($256) - Limited edition merchandise for investors only: XRHealth T-shirt)

Tier 2 perk ($512) - Limited edition merchandise for investors only: XRHealth signature coin)

Tier 3 perk ($1,500) - Limited edition merchandise for investors only: XRHealth stress ball + signature coin + T-shirt)

Tier 4 perk ($3,000) - Exclusive webinar with Eran Orr, XRHealth CEO, "Overview about Healthcare and XR") 

Tier 5 perk ($5,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps)

Tier 6 perk ($10,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps + 1:1 meeting with Eran Orr, XRHealth CEO, on Zoom) 

*All perks occur when the offering is completed.

Irregular Use of Proceeds

We will not incur any irregular use of proceeds.


Article Image
VR Focus

VRHealth To Make Its Medical Platform Available For Use At Home

Article Image
Times Magazine

The Coronavirus Outbreak Could Finally Make Telemedicine Mainstream in the U.S.

Article Image
Rachel Ray Show

Medical Virtual Reality featured on the Rachael Ray Show.

Article Image
MobiHealth News

VRHealth, AARP launch VR platform for remote patient monitoring, in-home therapy

Article Image

How virtual reality can help you manage pain



Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into XRHealth.




Calvin Nguyen

2 years ago

What's your monthly burn? When do you anticipate rapid-growth from user adoption? VR is still new is "metaverse" is still in its infancy contrary to what the news make people believe (still 5 years out at a minimum). VR adoption continues to grow, but only within a small niche and limited to tech savvy groups whereas I feel like this targets the general population, so how will you overcome this?




Scott Schwartz

2 years ago

Have you thought about integrating this with the Quest 2 or other Meta (Facebook) plans? There will be thousands of these in service.



Cho Yee Kong

a year ago

Any Schedule for the perk delivery? Thanks.



Paul Moravec

2 years ago

Hello, just curious about estimated shipping date of the VR headset with subscription that was promised to investors putting inn$5k. Thanks.



Yosef Hertz

2 years ago

I am pasting my question again, still haven't gotten a response, plz reply: Hi, can you update recent revenue traction, where did Q4 revenue come in at? With the metaverse trending during Q4 I'd think there would be a strong uptick in downloads. Can you indicate if and where you've seen growth? Also, from looking at online reviews it seems there are a lot of positives but company culture has not been strong in the past. How are you improving on this, so that employees are retained and happy? A number of employees that I saw left too soon after joining. Thanks



Yosef Hertz

2 years ago

Hi, can you update recent revenue traction, where did Q4 revenue come in at? With the metaverse trending during Q4 I'd think there would be a strong uptick in downloads. Can you indicate if and where you've seen growth? Also, from looking at online reviews it seems there are a lot of positives but company culture has not been strong in the past. How are you improving on this, so that employees are retained and happy? A number of employees that I saw left too soon after joining. Thanks



Vin P

2 years ago

Thx for a previous response! It'll be interesting & attractive to know what XRHealth would consider it's moat. What would stop the Health giants from entering this field, as post-Covid, TeleHealth is a reality.



Vin P

2 years ago

Hi, interesting opportunity. Appreciate input on exit strategy for a small investor. Thx.



Karim Kibaa

2 years ago

That is a crazy valuation compared to your revenue, i am so in the idea but the valuation is so high.



kymba nijuck

2 years ago

I was a patient of XR Health. They assured me on multiple occasions prior to receiving services that their services would be completely covered by my insurance, it was not. They told me that their physical therapist had experience with one of my conditions, she did not and gave me an exercise that literally was the first result that one would find on google for an exercise for that condition. Because of my negative experiences, I left a 1-star review on Google. In response, several of the top-level executives at XR Health left fraudulent/conflict of interest reviews in an attempt to bury my 1-star review. And they did so in such an inept manner as to be laughable. Of the 10 reviews currently on Google, 3 are from people with no history of making reviews and six are obviously from XR Health staff, including executives and... wait for it... their Social Marketing person! Clair Polansky - Content & Social Marketing Eran Orr - Founder & CEO Tal Arbel - VP Product Data & AI Shira Orr - Manager - Medical & Scientific Publications Kate Gleason - Clinic Director Noa Lustgarten - Director, Clinical Delivery Feel free to Google any of the above names + "XR Health". These folks are obviously not rocket scientists, have questionable ethics, and do not understand Google's Terms and Conditions. I think you can find better people to invest with.




Cancel anytime before 48 hours before a rolling close or the offering end date.



We want you to succeed and get the most out of your money by offering rewards and memberships!


Your info is your info. We take pride in keeping it that way!


Invest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.


Get To Know Us

Our Team



Important Message

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRASIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

Investment opportunities posted and accessible through the site are of three types:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information

(800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to

StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.

StartEngine Marketplace

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine.

None of the information displayed on or downloadable from (the 'Website') represents a recommendation, offer, or solicitation of an offer to buy or sell any security. It also does not constitute an offer to provide investment advice or service. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, or (2) assist in the determination of fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.

All investment opportunities are based on indicated interest from sellers and will need to be confirmed.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC. StartEngine Bulletin Board ("SE BB") is a bulletin board platform that advertises interest in shares of private companies that previously executed Reg CF or Reg A offerings. SE BB enables shareholders to communicate interest in potential sales of shares in private companies and investors to discover, review, and potentially invest in private companies. As a bulletin board platform, SE BB provides a venue for investors to access information about private company offerings and connect with potential sellers. SE BB is distinct and separate from StartEngine Secondary (“SE Secondary”), which is an SEC-registered Alternative Trading System (ATS) operated by SE Primary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. While a security may be displayed on the bulletin board, these securities will be subject to certain restrictions which may prevent the ability to buy and sell these securities in a timely manner, if at all. Even if a security is qualified to be displayed on the bulletin board, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.